IL15 and neoplasm: In addition to the reduced potency of immunocytokines and the local delivery and tumor conditional activation of IL-15, the identification and targeting of IL-15 signaling checkpoints is also gaining interest as an approach to increase the therapeutic index of targeting IL-15R.